(Q62015508)
Statements
Impact of FLT3 mutations and secondary cytogenetic changes on the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with a single agent arsenic trioxide regimen (English)
Vikram Mathews
Vivi M Srivastava
Biju George